Skip to main content

Table 3 Summary of clinical examination results in each Dobermann subcohort of the main cohort. N in the “Subcohort” column refers to the number of dogs in each group, and N in the other columns refers to the number of dogs from whom the corresponding parameter was available

From: Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human

Subcohort

Metrics

Age (years)

Weight (kg)

LVEDV/BSA (ml)

LVESV/BSA (ml)

LVIDd (cm)

LVIDs (cm)

LA/Ao

FS (%)

VPC (N)

Healthy (N = 148)

N

148

148

148

148

148

148

148

148

148

Mdn

8.40

35.05

72.30

36.30

4.01

2.96

1.28

26.00

4.00

SD

1.63

5.07

10.64

7.70

11.33

2.02

0.87

5.68

29.98

Q1

7.20

31.00

66.91

30.01

3.65

2.69

1.16

23.18

1.00

Q3

9.40

38.40

80.45

42.62

4.23

3.24

1.35

29.50

9.00

Arrhythmia only (N = 70)

N

70

68

67

67

66

56

68

65

69

Mdn

8.25

34.8

81.51

41.70

4.38

3.29

1.24

24.00

1602.00

SD

2.55

5.47

12.25

9.19

15.40

0.42

0.15

6.06

7478.22

Q1

6.00

32.20

73.13

36.49

4.12

3.00

1.17

20.00

497.00

Q3

9.00

39.00

90.19

48.90

4.62

3.58

1.41

27.00

3966.00

Echo only (N = 45)

N

45

45

45

45

44

40

45

44

45

Mdn

6.00

34.40

114.98

71.12

5.11

4.19

1.33

17.36

6.00

SD

2.94

7.00

25.79

22.27

15.18

0.59

0.29

5.12

29.03

Q1

4.00

32.40

102.75

61.74

4.83

3.80

1.21

13.48

3.00

Q3

8.00

42.90

130.85

89.60

5.53

4.60

1.47

21.00

21.00

Echo + arrhythmia (N = 113)

N

113

106

101

100

100

98

101

100

110

Mdn

8.00

38.00

109.50

69.00

5.04

4.12

1.35

17.31

563.00

SD

2.50

5.31

27.42

25.13

7.30

0.79

0.27

6.79

6117.55

Q1

6.00

34.20

100.51

60.71

4.74

3.79

1.27

12.75

165.00

Q3

9.00

41.20

132.61

84.89

5.53

4.64

1.44

21.00

3475.00

CHF (N = 55)

N

55

52

54

54

54

54

53

54

52

Mdn

7.00

34.95

159.16

116.65

6.09

5.12

2.07

13.55

835.00

SD

2.33

5.62

46.55

42.22

0.75

0.82

0.61

6.50

41,535.74

Q1

5.256

31.90

133.80

91.26

5.49

4.53

1.82

9.24

136.00

Q3

9.00

40.00

196.10

139.16

6.44

5.68

2.49

17.26

2781.00

  1. BSA body surface area, CHF congestive heart failure, FS fractional shortening, LA/Ao left atrial to aortic root diameter ratio, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVIDd left ventricular internal diameter end-diastole, LVIDs left ventricular internal diameter end-systole, Mdn median, Q1 lower quartile, Q3 upper quartile, SD standard deviation, VPC ventricular premature complex